[
  {
    "id": "metformin",
    "name": "Metformin",
    "searchTerms": [
      "metformin",
      "glucophage"
    ],
    "className": "Biguanide, oral hypoglycaemic",
    "tags": [
      "Diabetes",
      "eGFR-based"
    ],
    "usualDose": "Typically 1\u20132 g/day in divided doses (max 2\u20133 g/day depending on prep).",
    "renalBands": [
      {
        "min": 60,
        "max": null,
        "label": "eGFR \u2265 60 mL/min/1.73 m\u00b2",
        "category": "No dose change",
        "details": "Usual dosing with annual renal monitoring and checks before contrast/surgery."
      },
      {
        "min": 45,
        "max": 60,
        "label": "eGFR 45\u201359 mL/min/1.73 m\u00b2",
        "category": "Caution",
        "details": "Standard doses often fine; increase monitoring frequency and avoid starting in very high-risk patients."
      },
      {
        "min": 30,
        "max": 45,
        "label": "eGFR 30\u201344 mL/min/1.73 m\u00b2",
        "category": "Dose reduction",
        "details": "Reduce total daily dose (e.g. ~50%) and monitor 3-monthly. Stop during acute illness or dehydration."
      },
      {
        "min": null,
        "max": 30,
        "label": "eGFR < 30 mL/min/1.73 m\u00b2",
        "category": "Avoid",
        "details": "Avoid metformin due to lactic acidosis risk; use alternative glucose-lowering strategy."
      }
    ],
    "notes": [
      "Stop temporarily for sepsis, dehydration, hypoxia, contrast and major surgery."
    ]
  },
  {
    "id": "gliclazide",
    "name": "Gliclazide",
    "searchTerms": [
      "gliclazide"
    ],
    "className": "Sulfonylurea",
    "tags": [
      "Diabetes",
      "Hypoglycaemia risk"
    ],
    "usualDose": "40\u2013320 mg/day in 1\u20132 doses (MR usually once daily).",
    "renalBands": [
      {
        "min": 60,
        "max": null,
        "label": "eGFR \u2265 60",
        "category": "Standard dosing",
        "details": "Use usual titration; monitor for hypoglycaemia."
      },
      {
        "min": 30,
        "max": 60,
        "label": "eGFR 30\u201359",
        "category": "Caution",
        "details": "Lower starting dose and cautious titration; increased risk of prolonged hypos."
      },
      {
        "min": 15,
        "max": 30,
        "label": "eGFR 15\u201329",
        "category": "Use with care",
        "details": "Prefer alternatives; if used, very low doses with close monitoring."
      },
      {
        "min": null,
        "max": 15,
        "label": "eGFR < 15",
        "category": "Generally avoid",
        "details": "Avoid because of significant hypoglycaemia risk."
      }
    ],
    "notes": [
      "Warn about driving and hypos, especially as renal function declines."
    ]
  },
  {
    "id": "insulin-basal",
    "name": "Basal insulin (e.g. insulin glargine)",
    "searchTerms": [
      "insulin",
      "glargine",
      "lantus",
      "abasaglar"
    ],
    "className": "Basal insulin analogue",
    "tags": [
      "Diabetes"
    ],
    "usualDose": "Once or twice daily, fully individualised by glucose profile.",
    "renalBands": [
      {
        "min": null,
        "max": null,
        "label": "All eGFR ranges",
        "category": "Adjust to glucose",
        "details": "No fixed renal table; insulin requirements usually fall as eGFR declines. Use glucose readings to titrate."
      }
    ],
    "notes": [
      "Hypoglycaemia risk rises in CKD; review total insulin dose regularly."
    ]
  },
  {
    "id": "empagliflozin",
    "name": "Empagliflozin",
    "searchTerms": [
      "empagliflozin",
      "jardiance"
    ],
    "className": "SGLT2 inhibitor",
    "tags": [
      "Diabetes",
      "HF",
      "CKD"
    ],
    "usualDose": "10\u201325 mg once daily depending on indication.",
    "renalBands": [
      {
        "min": 60,
        "max": null,
        "label": "eGFR \u2265 60",
        "category": "Standard use",
        "details": "Usual doses for T2DM/HF/CKD as per SPC."
      },
      {
        "min": 20,
        "max": 60,
        "label": "eGFR 20\u201359",
        "category": "Indication-dependent",
        "details": "For HF/CKD, can often continue or initiate down to eGFR ~20; glucose-lowering effect reduced."
      },
      {
        "min": null,
        "max": 20,
        "label": "eGFR < 20",
        "category": "Check SPC",
        "details": "Often avoid initiating; continuing therapy requires specialist/label-based decision."
      }
    ],
    "notes": [
      "Follow SPC and local HF/CKD guidance for exact eGFR cut-offs."
    ]
  },
  {
    "id": "dapagliflozin",
    "name": "Dapagliflozin",
    "searchTerms": [
      "dapagliflozin",
      "forxiga"
    ],
    "className": "SGLT2 inhibitor",
    "tags": [
      "Diabetes",
      "HF",
      "CKD"
    ],
    "usualDose": "10 mg once daily.",
    "renalBands": [
      {
        "min": 60,
        "max": null,
        "label": "eGFR \u2265 60",
        "category": "Standard use",
        "details": "Use per SPC for T2DM/HF/CKD."
      },
      {
        "min": 15,
        "max": 60,
        "label": "eGFR 15\u201359",
        "category": "Indication-dependent",
        "details": "For HF/CKD indications can often be used down to eGFR ~15; minimal glycaemic effect at lower eGFR."
      },
      {
        "min": null,
        "max": 15,
        "label": "eGFR < 15",
        "category": "Avoid / specialist",
        "details": "Usually avoid; refer to SPC and renal/cardiology advice."
      }
    ],
    "notes": [
      "Monitor for genital infections, volume depletion and DKA risk."
    ]
  },
  {
    "id": "ramipril",
    "name": "Ramipril",
    "searchTerms": [
      "ramipril"
    ],
    "className": "ACE inhibitor",
    "tags": [
      "HF",
      "Hypertension"
    ],
    "usualDose": "2.5\u201310 mg once daily depending on indication.",
    "renalBands": [
      {
        "min": 60,
        "max": null,
        "label": "eGFR \u2265 60",
        "category": "Standard titration",
        "details": "Titrate to target with creatinine/potassium checks."
      },
      {
        "min": 30,
        "max": 60,
        "label": "eGFR 30\u201359",
        "category": "Start low, go slow",
        "details": "Start at low dose and titrate cautiously; stop/tweak if creatinine rises >~30% or K\u207a increases."
      },
      {
        "min": 15,
        "max": 30,
        "label": "eGFR 15\u201329",
        "category": "Careful use",
        "details": "Very low doses with frequent monitoring; consider nephrology/cardiology advice."
      },
      {
        "min": null,
        "max": 15,
        "label": "eGFR < 15",
        "category": "Specialist decision",
        "details": "Use only on specialist advice."
      }
    ],
    "notes": [
      "Apply sick-day rules \u2013 hold during dehydration/AKI risk."
    ]
  },
  {
    "id": "lisinopril",
    "name": "Lisinopril",
    "searchTerms": [
      "lisinopril"
    ],
    "className": "ACE inhibitor",
    "tags": [
      "Hypertension",
      "HF"
    ],
    "usualDose": "5\u201340 mg once daily depending on indication.",
    "renalBands": [
      {
        "min": 60,
        "max": null,
        "label": "eGFR \u2265 60",
        "category": "Standard",
        "details": "Use usual titration with monitoring."
      },
      {
        "min": 30,
        "max": 60,
        "label": "eGFR 30\u201359",
        "category": "Lower start",
        "details": "Start at low dose and titrate slowly with U&E checks."
      },
      {
        "min": null,
        "max": 30,
        "label": "eGFR < 30",
        "category": "Specialist / cautious",
        "details": "Low-dose use only with close monitoring and often specialist input."
      }
    ],
    "notes": [
      "Monitoring strategy similar to ramipril."
    ]
  },
  {
    "id": "losartan",
    "name": "Losartan",
    "searchTerms": [
      "losartan",
      "cozaar"
    ],
    "className": "ARB",
    "tags": [
      "Hypertension",
      "HF",
      "Diabetic nephropathy"
    ],
    "usualDose": "25\u2013100 mg once daily.",
    "renalBands": [
      {
        "min": 60,
        "max": null,
        "label": "eGFR \u2265 60",
        "category": "Standard",
        "details": "Usual doses with U&E monitoring."
      },
      {
        "min": 30,
        "max": 60,
        "label": "eGFR 30\u201359",
        "category": "Lower starting dose",
        "details": "Start at 25\u201350 mg and titrate slowly."
      },
      {
        "min": null,
        "max": 30,
        "label": "eGFR < 30",
        "category": "Specialist / cautious",
        "details": "Low doses only with frequent monitoring or specialist advice."
      }
    ],
    "notes": [
      "ARB monitoring and cautions similar to ACE inhibitors."
    ]
  },
  {
    "id": "candesartan",
    "name": "Candesartan",
    "searchTerms": [
      "candesartan"
    ],
    "className": "ARB",
    "tags": [
      "HF",
      "Hypertension"
    ],
    "usualDose": "4\u201332 mg once daily, indication-dependent.",
    "renalBands": [
      {
        "min": 60,
        "max": null,
        "label": "eGFR \u2265 60",
        "category": "Standard",
        "details": "Use usual titration with renal and potassium checks."
      },
      {
        "min": 30,
        "max": 60,
        "label": "eGFR 30\u201359",
        "category": "Cautious titration",
        "details": "Use lower starting doses and titrate carefully."
      },
      {
        "min": null,
        "max": 30,
        "label": "eGFR < 30",
        "category": "Specialist",
        "details": "Low-dose use only with frequent U&E monitoring / specialist advice."
      }
    ],
    "notes": [
      "Commonly used in HF; follow local HF titration protocol if available."
    ]
  },
  {
    "id": "bisoprolol",
    "name": "Bisoprolol",
    "searchTerms": [
      "bisoprolol"
    ],
    "className": "Beta-1 selective beta-blocker",
    "tags": [
      "HF",
      "Hypertension"
    ],
    "usualDose": "Heart failure: 1.25\u201310 mg once daily.",
    "renalBands": [
      {
        "min": 60,
        "max": null,
        "label": "eGFR \u2265 60",
        "category": "Standard titration",
        "details": "Titrate per HF/HTN protocol."
      },
      {
        "min": 30,
        "max": 60,
        "label": "eGFR 30\u201359",
        "category": "No formal change",
        "details": "Usually no structured dose change, but titrate slowly in frail/CKD."
      },
      {
        "min": null,
        "max": 30,
        "label": "eGFR < 30",
        "category": "Caution",
        "details": "Monitor closely for bradycardia/hypotension; specialist advice in advanced CKD."
      }
    ],
    "notes": [
      "Partly renally cleared; accumulation may contribute to bradycardia in CKD."
    ]
  },
  {
    "id": "furosemide",
    "name": "Furosemide",
    "searchTerms": [
      "furosemide",
      "frusemide"
    ],
    "className": "Loop diuretic",
    "tags": [
      "HF",
      "Oedema"
    ],
    "usualDose": "20\u201380 mg once or twice daily; higher doses in CKD.",
    "renalBands": [
      {
        "min": 60,
        "max": null,
        "label": "eGFR \u2265 60",
        "category": "Standard",
        "details": "Use lowest effective dose with monitoring of U&E and volume status."
      },
      {
        "min": 30,
        "max": 60,
        "label": "eGFR 30\u201359",
        "category": "Higher doses often",
        "details": "May need higher doses; monitor for AKI and electrolyte disturbance."
      },
      {
        "min": 15,
        "max": 30,
        "label": "eGFR 15\u201329",
        "category": "Specialist titration",
        "details": "High doses and/or IV often required; usually titrated by HF/renal teams."
      },
      {
        "min": null,
        "max": 15,
        "label": "eGFR < 15 / dialysis",
        "category": "Individualised",
        "details": "Use only with specialist guidance."
      }
    ],
    "notes": [
      "Avoid over-diuresis; assess weight, JVP, BP and renal function."
    ]
  },
  {
    "id": "spironolactone",
    "name": "Spironolactone",
    "searchTerms": [
      "spironolactone"
    ],
    "className": "Aldosterone antagonist",
    "tags": [
      "HF",
      "Hyperkalaemia risk"
    ],
    "usualDose": "HF: typically 25\u201350 mg once daily.",
    "renalBands": [
      {
        "min": 60,
        "max": null,
        "label": "eGFR \u2265 60",
        "category": "Standard low dose",
        "details": "Use usual HF doses with U&E monitoring."
      },
      {
        "min": 45,
        "max": 60,
        "label": "eGFR 45\u201359",
        "category": "Caution",
        "details": "Consider 25 mg on alternate days and closer K\u207a monitoring."
      },
      {
        "min": 30,
        "max": 45,
        "label": "eGFR 30\u201344",
        "category": "High hyperkalaemia risk",
        "details": "Often avoid or use very low doses with frequent U&E."
      },
      {
        "min": null,
        "max": 30,
        "label": "eGFR < 30",
        "category": "Generally avoid",
        "details": "Usually avoided outside specialist settings."
      }
    ],
    "notes": [
      "Stop or reduce if K\u207a rises or creatinine increases significantly."
    ]
  },
  {
    "id": "atorvastatin",
    "name": "Atorvastatin",
    "searchTerms": [
      "atorvastatin"
    ],
    "className": "Statin",
    "tags": [
      "Lipids"
    ],
    "usualDose": "10\u201380 mg once daily.",
    "renalBands": [
      {
        "min": null,
        "max": null,
        "label": "All eGFR ranges",
        "category": "No formal renal adjustment",
        "details": "Generally no structured dose change; use usual CKD dose recommendations (often 20 mg+ for secondary prevention)."
      }
    ],
    "notes": [
      "Monitor for myopathy; adjust if CK or symptoms problematic."
    ]
  },
  {
    "id": "simvastatin",
    "name": "Simvastatin",
    "searchTerms": [
      "simvastatin"
    ],
    "className": "Statin",
    "tags": [
      "Lipids"
    ],
    "usualDose": "10\u201340 mg once daily in the evening.",
    "renalBands": [
      {
        "min": 60,
        "max": null,
        "label": "eGFR \u2265 60",
        "category": "Standard",
        "details": "Usual doses with routine monitoring."
      },
      {
        "min": null,
        "max": 60,
        "label": "eGFR < 60",
        "category": "No major change",
        "details": "Often no formal adjustment, but some guidance suggests lower starting doses in advanced CKD."
      }
    ],
    "notes": [
      "Be aware of drug interactions and myopathy risk."
    ]
  },
  {
    "id": "apixaban",
    "name": "Apixaban",
    "searchTerms": [
      "apixaban",
      "eliquis",
      "doac"
    ],
    "className": "Direct factor Xa inhibitor",
    "tags": [
      "DOAC",
      "AF",
      "VTE"
    ],
    "usualDose": "AF: 5 mg twice daily, or 2.5 mg twice daily if dose-reduction criteria.",
    "renalBands": [
      {
        "min": 50,
        "max": null,
        "label": "CrCl \u2265 50",
        "category": "Standard dosing",
        "details": "Use labelled dose for indication."
      },
      {
        "min": 30,
        "max": 50,
        "label": "CrCl 30\u201349",
        "category": "Caution / possible reduction",
        "details": "Often reduced dose in AF if criteria met; check SPC/SPS/local DOAC protocol."
      },
      {
        "min": 15,
        "max": 30,
        "label": "CrCl 15\u201329",
        "category": "Reduced dose / specialist",
        "details": "AF: usually 2.5 mg bd with caution; VTE often specialist-only decision."
      },
      {
        "min": null,
        "max": 15,
        "label": "CrCl < 15 / dialysis",
        "category": "Avoid",
        "details": "Most UK guidance: avoid DOACs and consider warfarin or no anticoagulation."
      }
    ],
    "notes": [
      "Always use Cockcroft\u2013Gault CrCl, not eGFR, for DOAC dosing."
    ]
  },
  {
    "id": "rivaroxaban",
    "name": "Rivaroxaban",
    "searchTerms": [
      "rivaroxaban",
      "xarelto",
      "doac"
    ],
    "className": "Direct factor Xa inhibitor",
    "tags": [
      "DOAC",
      "AF",
      "VTE"
    ],
    "usualDose": "AF: 20 mg od with food; 15 mg od if CrCl 15\u201349.",
    "renalBands": [
      {
        "min": 50,
        "max": null,
        "label": "CrCl \u2265 50",
        "category": "Standard",
        "details": "Use labelled dose for AF/VTE."
      },
      {
        "min": 15,
        "max": 50,
        "label": "CrCl 15\u201349",
        "category": "Reduced dose",
        "details": "AF: 15 mg od; check SPC and SPS for other indications."
      },
      {
        "min": null,
        "max": 15,
        "label": "CrCl < 15",
        "category": "Avoid",
        "details": "Avoid rivaroxaban; consider alternatives."
      }
    ],
    "notes": [
      "Assess bleeding risk and renal function regularly."
    ]
  },
  {
    "id": "edoxaban",
    "name": "Edoxaban",
    "searchTerms": [
      "edoxaban",
      "lixiana",
      "doac"
    ],
    "className": "Direct factor Xa inhibitor",
    "tags": [
      "DOAC",
      "AF",
      "VTE"
    ],
    "usualDose": "AF: 60 mg od; 30 mg od if CrCl 15\u201350, low weight or certain interactions.",
    "renalBands": [
      {
        "min": 50,
        "max": 95,
        "label": "CrCl 50\u201395",
        "category": "Standard",
        "details": "Use 60 mg od if other reduction criteria not met."
      },
      {
        "min": 15,
        "max": 50,
        "label": "CrCl 15\u201349",
        "category": "Reduced dose",
        "details": "Usually 30 mg od; check SPC."
      },
      {
        "min": null,
        "max": 15,
        "label": "CrCl < 15",
        "category": "Avoid",
        "details": "Avoid edoxaban; use alternative."
      }
    ],
    "notes": [
      "Avoid if CrCl > 95 mL/min in AF due to reduced efficacy."
    ]
  },
  {
    "id": "warfarin",
    "name": "Warfarin",
    "searchTerms": [
      "warfarin"
    ],
    "className": "Vitamin K antagonist",
    "tags": [
      "Anticoagulant"
    ],
    "usualDose": "Highly individualised to INR.",
    "renalBands": [
      {
        "min": null,
        "max": null,
        "label": "All eGFR ranges",
        "category": "INR-guided",
        "details": "No fixed renal adjustment; dose to INR within target range."
      }
    ],
    "notes": [
      "Bleeding risk higher in CKD; monitor INR and interactions closely."
    ]
  },
  {
    "id": "gabapentin",
    "name": "Gabapentin",
    "searchTerms": [
      "gabapentin",
      "neurontin"
    ],
    "className": "Antiepileptic / neuropathic pain",
    "tags": [
      "Neuropathic pain",
      "Renally cleared"
    ],
    "usualDose": "900\u20133600 mg/day in 3 doses in normal renal function.",
    "renalBands": [
      {
        "min": 60,
        "max": null,
        "label": "CrCl \u2265 60",
        "category": "Standard",
        "details": "Usual titration up to local max."
      },
      {
        "min": 30,
        "max": 60,
        "label": "CrCl 30\u201359",
        "category": "Moderate reduction",
        "details": "Reduce total daily dose and/or frequency (e.g. ~600\u20131800 mg/day)."
      },
      {
        "min": 15,
        "max": 30,
        "label": "CrCl 15\u201329",
        "category": "Significant reduction",
        "details": "Low doses (e.g. 300\u2013600 mg/day) with slow titration."
      },
      {
        "min": null,
        "max": 15,
        "label": "CrCl < 15 / dialysis",
        "category": "Specialist dosing",
        "details": "Very low or post-dialysis dosing only."
      }
    ],
    "notes": [
      "Accumulation causes sedation/ataxia; use CrCl rather than eGFR if possible."
    ]
  },
  {
    "id": "pregabalin",
    "name": "Pregabalin",
    "searchTerms": [
      "pregabalin",
      "lyrica"
    ],
    "className": "Antiepileptic / neuropathic pain / GAD",
    "tags": [
      "Neuropathic pain",
      "Renally cleared"
    ],
    "usualDose": "150\u2013600 mg/day in 2\u20133 divided doses.",
    "renalBands": [
      {
        "min": 60,
        "max": null,
        "label": "CrCl \u2265 60",
        "category": "Standard",
        "details": "Use usual titration schedule."
      },
      {
        "min": 30,
        "max": 60,
        "label": "CrCl 30\u201359",
        "category": "Dose reduction",
        "details": "Lower maximum daily dose (e.g. up to ~300 mg/day)."
      },
      {
        "min": 15,
        "max": 30,
        "label": "CrCl 15\u201329",
        "category": "Marked reduction",
        "details": "Substantially reduced doses (e.g. up to ~150 mg/day)."
      },
      {
        "min": null,
        "max": 15,
        "label": "CrCl < 15 / dialysis",
        "category": "Specialist",
        "details": "Very low/post-dialysis dosing only."
      }
    ],
    "notes": [
      "Accumulation increases sedation, dizziness and oedema; taper slowly when stopping."
    ]
  },
  {
    "id": "sertraline",
    "name": "Sertraline",
    "searchTerms": [
      "sertraline"
    ],
    "className": "SSRI antidepressant",
    "tags": [
      "Depression",
      "Anxiety"
    ],
    "usualDose": "50\u2013200 mg once daily.",
    "renalBands": [
      {
        "min": null,
        "max": null,
        "label": "All eGFR ranges",
        "category": "No formal adjustment",
        "details": "Usually no structured dose change; start low and titrate by response."
      }
    ],
    "notes": [
      "Monitor for hyponatraemia, especially in older patients and CKD."
    ]
  },
  {
    "id": "mirtazapine",
    "name": "Mirtazapine",
    "searchTerms": [
      "mirtazapine"
    ],
    "className": "NaSSA antidepressant",
    "tags": [
      "Depression"
    ],
    "usualDose": "15\u201345 mg at night.",
    "renalBands": [
      {
        "min": 40,
        "max": null,
        "label": "eGFR \u2265 40",
        "category": "Standard",
        "details": "Usual dose range with clinical monitoring."
      },
      {
        "min": null,
        "max": 40,
        "label": "eGFR < 40",
        "category": "Caution",
        "details": "Consider lower doses and slower titration; monitor for sedation."
      }
    ],
    "notes": [
      "Can cause weight gain and sedation; useful for insomnia/poor appetite."
    ]
  },
  {
    "id": "venlafaxine",
    "name": "Venlafaxine",
    "searchTerms": [
      "venlafaxine"
    ],
    "className": "SNRI antidepressant",
    "tags": [
      "Depression",
      "Anxiety"
    ],
    "usualDose": "75\u2013225 mg/day (immediate or modified-release).",
    "renalBands": [
      {
        "min": 60,
        "max": null,
        "label": "eGFR \u2265 60",
        "category": "Standard",
        "details": "Usual dose range as per BNF."
      },
      {
        "min": 30,
        "max": 60,
        "label": "eGFR 30\u201359",
        "category": "Dose reduction",
        "details": "Reduce total daily dose (e.g. by ~25\u201350%) and titrate slowly."
      },
      {
        "min": null,
        "max": 30,
        "label": "eGFR < 30",
        "category": "Further reduction",
        "details": "Use low doses only and monitor closely; consider alternatives in severe CKD."
      }
    ],
    "notes": [
      "Monitor BP and withdrawal symptoms on discontinuation."
    ]
  },
  {
    "id": "amitriptyline",
    "name": "Amitriptyline",
    "searchTerms": [
      "amitriptyline"
    ],
    "className": "Tricyclic antidepressant",
    "tags": [
      "Depression",
      "Neuropathic pain"
    ],
    "usualDose": "10\u201375 mg at night for pain (higher for depression under specialist care).",
    "renalBands": [
      {
        "min": null,
        "max": null,
        "label": "All eGFR ranges",
        "category": "Clinical titration",
        "details": "No formal renal table; start low and titrate by tolerability, particularly in older adults/CKD."
      }
    ],
    "notes": [
      "Anticholinergic and cardiac side-effects limit use in frailer CKD patients."
    ]
  },
  {
    "id": "amoxicillin",
    "name": "Amoxicillin",
    "searchTerms": [
      "amoxicillin"
    ],
    "className": "Aminopenicillin antibiotic",
    "tags": [
      "Antibiotic"
    ],
    "usualDose": "500 mg tds (higher for severe infection).",
    "renalBands": [
      {
        "min": 30,
        "max": null,
        "label": "eGFR \u2265 30",
        "category": "Standard",
        "details": "Usual dose and interval."
      },
      {
        "min": 10,
        "max": 30,
        "label": "eGFR 10\u201329",
        "category": "Extended interval",
        "details": "Reduce frequency (e.g. bd) according to severity and local guidance."
      },
      {
        "min": null,
        "max": 10,
        "label": "eGFR < 10 / dialysis",
        "category": "Further reduction",
        "details": "Lower dose or longer interval; seek renal/microbiology advice in severe infection."
      }
    ],
    "notes": [
      "Follow local antimicrobial guidance for indication and exact dosing."
    ]
  },
  {
    "id": "co-amoxiclav",
    "name": "Co-amoxiclav",
    "searchTerms": [
      "co-amoxiclav",
      "amoxicillin clavulanic"
    ],
    "className": "Amoxicillin + clavulanic acid",
    "tags": [
      "Antibiotic"
    ],
    "usualDose": "500/125 mg tds or 875/125 mg bd depending on prep.",
    "renalBands": [
      {
        "min": 30,
        "max": null,
        "label": "eGFR \u2265 30",
        "category": "Standard",
        "details": "Usual dosing per indication."
      },
      {
        "min": 10,
        "max": 30,
        "label": "eGFR 10\u201329",
        "category": "Extended interval",
        "details": "Reduce frequency (e.g. bd) as per BNF/local guidance."
      },
      {
        "min": null,
        "max": 10,
        "label": "eGFR < 10 / dialysis",
        "category": "Further reduction",
        "details": "Consider alternative or further dose/interval reduction with specialist advice."
      }
    ],
    "notes": [
      "Monitor LFTs if prolonged course; be aware of cholestatic hepatitis risk."
    ]
  },
  {
    "id": "nitrofurantoin",
    "name": "Nitrofurantoin",
    "searchTerms": [
      "nitrofurantoin",
      "macrobid"
    ],
    "className": "Urinary antibacterial",
    "tags": [
      "UTI"
    ],
    "usualDose": "100 mg MR bd or 50 mg qds for 3\u20137 days.",
    "renalBands": [
      {
        "min": 45,
        "max": null,
        "label": "eGFR \u2265 45",
        "category": "Standard short course",
        "details": "Use for lower UTI only if no upper tract features."
      },
      {
        "min": 30,
        "max": 45,
        "label": "eGFR 30\u201344",
        "category": "Short course only",
        "details": "Some guidance allows short-course use if benefits outweigh risks; avoid prophylaxis."
      },
      {
        "min": null,
        "max": 30,
        "label": "eGFR < 30",
        "category": "Avoid",
        "details": "Avoid due to poor urinary levels and higher toxicity risk."
      }
    ],
    "notes": [
      "Avoid in suspected pyelonephritis or sepsis."
    ]
  },
  {
    "id": "trimethoprim",
    "name": "Trimethoprim",
    "searchTerms": [
      "trimethoprim"
    ],
    "className": "Dihydrofolate reductase inhibitor",
    "tags": [
      "UTI",
      "Hyperkalaemia risk"
    ],
    "usualDose": "200 mg bd for 3\u20137 days (acute UTI).",
    "renalBands": [
      {
        "min": 30,
        "max": null,
        "label": "eGFR \u2265 30",
        "category": "Standard",
        "details": "Usual short course dosing."
      },
      {
        "min": 15,
        "max": 30,
        "label": "eGFR 15\u201329",
        "category": "Dose reduction",
        "details": "Reduce total dose or extend interval (e.g. 200 mg od)."
      },
      {
        "min": null,
        "max": 15,
        "label": "eGFR < 15",
        "category": "Avoid / specialist",
        "details": "Avoid if possible due to hyperkalaemia and creatinine rise."
      }
    ],
    "notes": [
      "Check K\u207a and creatinine if using in patients on ACEI/ARB/spironolactone."
    ]
  },
  {
    "id": "cefalexin",
    "name": "Cefalexin",
    "searchTerms": [
      "cefalexin",
      "cephalexin"
    ],
    "className": "1st-generation cephalosporin",
    "tags": [
      "Antibiotic"
    ],
    "usualDose": "500 mg bd\u2013qds depending on indication.",
    "renalBands": [
      {
        "min": 50,
        "max": null,
        "label": "eGFR \u2265 50",
        "category": "Standard",
        "details": "Usual dose and frequency."
      },
      {
        "min": 10,
        "max": 50,
        "label": "eGFR 10\u201349",
        "category": "Extended interval",
        "details": "Reduce frequency (e.g. bd) as per BNF/local guidance."
      },
      {
        "min": null,
        "max": 10,
        "label": "eGFR < 10",
        "category": "Further reduction",
        "details": "Low dose or longer interval; seek renal/micro advice in serious infection."
      }
    ],
    "notes": [
      "Watch for neurotoxicity at very low eGFR and high doses."
    ]
  },
  {
    "id": "digoxin",
    "name": "Digoxin",
    "searchTerms": [
      "digoxin"
    ],
    "className": "Cardiac glycoside",
    "tags": [
      "HF",
      "Rate control",
      "Narrow therapeutic index"
    ],
    "usualDose": "62.5\u2013250 micrograms od according to age, renal function and indication.",
    "renalBands": [
      {
        "min": 60,
        "max": null,
        "label": "eGFR \u2265 60",
        "category": "Standard low-ish dosing",
        "details": "Use lower doses in older adults; monitor levels if concern."
      },
      {
        "min": 30,
        "max": 60,
        "label": "eGFR 30\u201359",
        "category": "Dose reduction",
        "details": "Often 62.5\u2013125 micrograms od or on alternate days; check levels if possible."
      },
      {
        "min": 15,
        "max": 30,
        "label": "eGFR 15\u201329",
        "category": "Marked reduction",
        "details": "Very low doses (e.g. 62.5 micrograms od/alt days); monitor for toxicity."
      },
      {
        "min": null,
        "max": 15,
        "label": "eGFR < 15",
        "category": "Specialist dosing",
        "details": "Dose only with level monitoring and specialist supervision."
      }
    ],
    "notes": [
      "Toxicity risk rises in CKD, hypokalaemia and hypomagnesaemia; review interacting drugs."
    ]
  },
  {
    "id": "pioglitazone",
    "name": "Pioglitazone",
    "searchTerms": [
      "pioglitazone",
      "actos"
    ],
    "className": "Thiazolidinedione",
    "tags": [
      "Diabetes"
    ],
    "usualDose": "15\u201345 mg once daily.",
    "renalBands": [
      {
        "min": null,
        "max": null,
        "label": "All eGFR ranges",
        "category": "No formal renal adjustment",
        "details": "Dose is not primarily renally determined; use usual doses but avoid fluid overload in HF or advanced CKD."
      }
    ],
    "notes": [
      "Monitor weight and oedema; avoid in heart failure or high fracture risk.",
      "Review for bladder cancer risk factors as per SPC/local guidance."
    ]
  },
  {
    "id": "sitagliptin",
    "name": "Sitagliptin",
    "searchTerms": [
      "sitagliptin",
      "januvia"
    ],
    "className": "DPP-4 inhibitor",
    "tags": [
      "Diabetes",
      "Renally cleared"
    ],
    "usualDose": "100 mg once daily in normal renal function.",
    "renalBands": [
      {
        "min": 50,
        "max": null,
        "label": "eGFR \u2265 50",
        "category": "Standard",
        "details": "100 mg once daily."
      },
      {
        "min": 30,
        "max": 50,
        "label": "eGFR 30\u201349",
        "category": "Dose reduction",
        "details": "50 mg once daily."
      },
      {
        "min": 15,
        "max": 30,
        "label": "eGFR 15\u201329",
        "category": "Further reduction",
        "details": "25 mg once daily."
      },
      {
        "min": null,
        "max": 15,
        "label": "eGFR < 15 / dialysis",
        "category": "25 mg once daily (label-based)",
        "details": "Use 25 mg once daily with monitoring; check SPC/local guidance."
      }
    ],
    "notes": [
      "Low hypoglycaemia risk when used without sulfonylurea/insulin.",
      "Adjust doses of combination products accordingly."
    ]
  },
  {
    "id": "linagliptin",
    "name": "Linagliptin",
    "searchTerms": [
      "linagliptin",
      "trajenta"
    ],
    "className": "DPP-4 inhibitor",
    "tags": [
      "Diabetes"
    ],
    "usualDose": "5 mg once daily.",
    "renalBands": [
      {
        "min": null,
        "max": null,
        "label": "All eGFR ranges",
        "category": "No renal adjustment",
        "details": "Predominantly non-renal clearance; same dose across eGFR ranges as per SPC."
      }
    ],
    "notes": [
      "Low hypoglycaemia risk unless combined with sulfonylurea/insulin.",
      "Useful option in advanced CKD when DPP-4 inhibition is required."
    ]
  },
  {
    "id": "amlodipine",
    "name": "Amlodipine",
    "searchTerms": [
      "amlodipine"
    ],
    "className": "Dihydropyridine calcium-channel blocker",
    "tags": [
      "Hypertension",
      "Angina"
    ],
    "usualDose": "5\u201310 mg once daily.",
    "renalBands": [
      {
        "min": null,
        "max": null,
        "label": "All eGFR ranges",
        "category": "No formal adjustment",
        "details": "Not significantly renally cleared; use usual doses with BP and oedema monitoring."
      }
    ],
    "notes": [
      "Peripheral oedema is common; may worsen with advanced CKD.",
      "Avoid abrupt withdrawal in angina."
    ]
  },
  {
    "id": "doxazosin",
    "name": "Doxazosin",
    "searchTerms": [
      "doxazosin"
    ],
    "className": "Alpha-1 blocker",
    "tags": [
      "Hypertension",
      "BPH"
    ],
    "usualDose": "1\u201316 mg once daily (or modified-release) depending on indication.",
    "renalBands": [
      {
        "min": null,
        "max": null,
        "label": "All eGFR ranges",
        "category": "No formal adjustment",
        "details": "Metabolised hepatically; use usual doses but start low and titrate carefully in older people and CKD."
      }
    ],
    "notes": [
      "Monitor for postural hypotension and falls.",
      "Useful as add-on therapy in resistant hypertension."
    ]
  },
  {
    "id": "indapamide",
    "name": "Indapamide",
    "searchTerms": [
      "indapamide"
    ],
    "className": "Thiazide-like diuretic",
    "tags": [
      "Hypertension"
    ],
    "usualDose": "1.5 mg MR once daily or 2.5 mg once daily.",
    "renalBands": [
      {
        "min": 30,
        "max": null,
        "label": "eGFR \u2265 30",
        "category": "Standard",
        "details": "Usual doses may be used with U&E monitoring."
      },
      {
        "min": null,
        "max": 30,
        "label": "eGFR < 30",
        "category": "Reduced efficacy",
        "details": "Less effective as a diuretic in eGFR < 30; consider loop diuretic instead for fluid control."
      }
    ],
    "notes": [
      "Monitor sodium, potassium and urate.",
      "Use cautiously with other drugs causing hyponatraemia."
    ]
  },
  {
    "id": "bendroflumethiazide",
    "name": "Bendroflumethiazide",
    "searchTerms": [
      "bendroflumethiazide"
    ],
    "className": "Thiazide diuretic",
    "tags": [
      "Hypertension"
    ],
    "usualDose": "2.5 mg once daily for hypertension (higher doses for oedema).",
    "renalBands": [
      {
        "min": 30,
        "max": null,
        "label": "eGFR \u2265 30",
        "category": "Standard",
        "details": "May be used for hypertension with monitoring of electrolytes."
      },
      {
        "min": null,
        "max": 30,
        "label": "eGFR < 30",
        "category": "Generally avoid",
        "details": "Ineffective as diuretic and increased risk of toxicity; loop diuretic preferred for oedema."
      }
    ],
    "notes": [
      "Monitor sodium and potassium, particularly in older adults.",
      "Can increase urate and glucose."
    ]
  },
  {
    "id": "sacubitril-valsartan",
    "name": "Sacubitril / valsartan",
    "searchTerms": [
      "sacubitril",
      "entresto",
      "sacubitril valsartan"
    ],
    "className": "ARNI (angiotensin receptor\u2013neprilysin inhibitor)",
    "tags": [
      "Heart failure"
    ],
    "usualDose": "Target 97/103 mg twice daily after titration from lower strengths.",
    "renalBands": [
      {
        "min": 60,
        "max": null,
        "label": "eGFR \u2265 60",
        "category": "Standard initiation",
        "details": "Start at appropriate strength and titrate to target as tolerated, with close U&E monitoring."
      },
      {
        "min": 30,
        "max": 60,
        "label": "eGFR 30\u201359",
        "category": "Lower start",
        "details": "Start at lowest strength and titrate cautiously with frequent checks of creatinine and potassium."
      },
      {
        "min": 15,
        "max": 30,
        "label": "eGFR 15\u201329",
        "category": "Specialist use",
        "details": "Use only under specialist HF supervision with close U&E monitoring."
      },
      {
        "min": null,
        "max": 15,
        "label": "eGFR < 15 / dialysis",
        "category": "Avoid",
        "details": "Generally avoided in severe renal impairment; seek specialist advice."
      }
    ],
    "notes": [
      "Must not be co-administered with ACE inhibitors (36-hour washout required).",
      "Monitor for hypotension, hyperkalaemia and renal dysfunction."
    ]
  },
  {
    "id": "aspirin-lowdose",
    "name": "Aspirin (75 mg for CV prevention)",
    "searchTerms": [
      "aspirin",
      "low-dose aspirin"
    ],
    "className": "Antiplatelet",
    "tags": [
      "Antiplatelet"
    ],
    "usualDose": "75 mg once daily.",
    "renalBands": [
      {
        "min": null,
        "max": null,
        "label": "All eGFR ranges",
        "category": "No formal dose adjustment",
        "details": "Low-dose aspirin is not usually renally adjusted, but bleeding risk is higher in CKD."
      }
    ],
    "notes": [
      "Consider gastroprotection in high-risk patients.",
      "Use with caution in advanced CKD with bleeding tendency."
    ]
  },
  {
    "id": "clopidogrel",
    "name": "Clopidogrel",
    "searchTerms": [
      "clopidogrel"
    ],
    "className": "P2Y12 inhibitor antiplatelet",
    "tags": [
      "Antiplatelet"
    ],
    "usualDose": "75 mg once daily (after loading dose in ACS/PCI).",
    "renalBands": [
      {
        "min": null,
        "max": null,
        "label": "All eGFR ranges",
        "category": "No formal adjustment",
        "details": "No usual dose change with renal impairment, but bleeding risk is increased in CKD."
      }
    ],
    "notes": [
      "Assess bleeding vs thrombotic risk carefully in advanced CKD.",
      "Avoid use with proton pump inhibitors that strongly inhibit CYP2C19 unless necessary."
    ]
  },
  {
    "id": "rosuvastatin",
    "name": "Rosuvastatin",
    "searchTerms": [
      "rosuvastatin",
      "crestor"
    ],
    "className": "Statin",
    "tags": [
      "Lipids"
    ],
    "usualDose": "5\u201340 mg once daily depending on indication and risk.",
    "renalBands": [
      {
        "min": 60,
        "max": null,
        "label": "eGFR \u2265 60",
        "category": "Standard",
        "details": "Use labelled dose range with monitoring."
      },
      {
        "min": 30,
        "max": 60,
        "label": "eGFR 30\u201359",
        "category": "Lower starting dose",
        "details": "Start at low dose (e.g. 5\u201310 mg) and titrate; higher doses may be used with caution."
      },
      {
        "min": null,
        "max": 30,
        "label": "eGFR < 30",
        "category": "Reduced maximum",
        "details": "Maximum dose is reduced; check SPC/BNF for current maxima (e.g. 10\u201320 mg)."
      }
    ],
    "notes": [
      "Monitor for muscle symptoms and CK if indicated.",
      "Consider alternative statin if intolerance."
    ]
  },
  {
    "id": "ezetimibe",
    "name": "Ezetimibe",
    "searchTerms": [
      "ezetimibe"
    ],
    "className": "Cholesterol absorption inhibitor",
    "tags": [
      "Lipids"
    ],
    "usualDose": "10 mg once daily.",
    "renalBands": [
      {
        "min": null,
        "max": null,
        "label": "All eGFR ranges",
        "category": "No renal adjustment",
        "details": "No dose change usually required in CKD."
      }
    ],
    "notes": [
      "Often used as add-on to statin therapy.",
      "Monitor LFTs when combined with statin."
    ]
  },
  {
    "id": "salbutamol-inhaled",
    "name": "Salbutamol (inhaled)",
    "searchTerms": [
      "salbutamol",
      "ventolin"
    ],
    "className": "Short-acting beta-2 agonist",
    "tags": [
      "Asthma",
      "COPD"
    ],
    "usualDose": "100\u2013200 micrograms prn by inhaler.",
    "renalBands": [
      {
        "min": null,
        "max": null,
        "label": "All eGFR ranges",
        "category": "No renal adjustment",
        "details": "Inhaled doses are not renally adjusted; monitor potassium if frequent high-dose use in CKD."
      }
    ],
    "notes": [
      "High-dose nebulised therapy can cause hypokalaemia; monitor in severe CKD/AKI."
    ]
  },
  {
    "id": "tiotropium",
    "name": "Tiotropium (inhaled)",
    "searchTerms": [
      "tiotropium",
      "spiriva"
    ],
    "className": "Long-acting muscarinic antagonist",
    "tags": [
      "COPD",
      "Asthma"
    ],
    "usualDose": "Once daily inhaled dose according to device.",
    "renalBands": [
      {
        "min": 60,
        "max": null,
        "label": "eGFR \u2265 60",
        "category": "Standard",
        "details": "Usual dose."
      },
      {
        "min": null,
        "max": 60,
        "label": "eGFR < 60",
        "category": "Caution",
        "details": "Small increase in systemic exposure; monitor for anticholinergic side effects but usually no dose change."
      }
    ],
    "notes": [
      "Use with caution in urinary retention or narrow-angle glaucoma."
    ]
  },
  {
    "id": "budesonide-formoterol",
    "name": "Budesonide/formoterol (inhaler)",
    "searchTerms": [
      "budesonide",
      "formoterol",
      "symbicort"
    ],
    "className": "ICS/LABA combination",
    "tags": [
      "Asthma",
      "COPD"
    ],
    "usualDose": "Dose depends on strength and MART vs fixed regimen.",
    "renalBands": [
      {
        "min": null,
        "max": null,
        "label": "All eGFR ranges",
        "category": "No renal adjustment",
        "details": "Inhaled combination not renally adjusted."
      }
    ],
    "notes": [
      "Follow national asthma/COPD guidance for dose selection.",
      "Rinse mouth after use to reduce thrush risk."
    ]
  },
  {
    "id": "omeprazole",
    "name": "Omeprazole",
    "searchTerms": [
      "omeprazole"
    ],
    "className": "Proton pump inhibitor",
    "tags": [
      "PPI",
      "GI"
    ],
    "usualDose": "20\u201340 mg once daily depending on indication.",
    "renalBands": [
      {
        "min": null,
        "max": null,
        "label": "All eGFR ranges",
        "category": "No renal adjustment",
        "details": "No formal dose change required in CKD."
      }
    ],
    "notes": [
      "Long-term use associated with hypomagnesaemia, fractures and C. difficile; review need regularly."
    ]
  },
  {
    "id": "lansoprazole",
    "name": "Lansoprazole",
    "searchTerms": [
      "lansoprazole"
    ],
    "className": "Proton pump inhibitor",
    "tags": [
      "PPI",
      "GI"
    ],
    "usualDose": "15\u201330 mg once daily.",
    "renalBands": [
      {
        "min": null,
        "max": null,
        "label": "All eGFR ranges",
        "category": "No renal adjustment",
        "details": "No dose change usually required."
      }
    ],
    "notes": [
      "As with other PPIs, periodically review long-term therapy."
    ]
  },
  {
    "id": "loperamide",
    "name": "Loperamide",
    "searchTerms": [
      "loperamide",
      "imodium"
    ],
    "className": "Antidiarrhoeal",
    "tags": [
      "GI"
    ],
    "usualDose": "Up to 16 mg/day in divided doses for acute diarrhoea.",
    "renalBands": [
      {
        "min": null,
        "max": null,
        "label": "All eGFR ranges",
        "category": "No renal adjustment",
        "details": "Not renally dose-adjusted; avoid in acute colitis and use cautiously in hepatic impairment."
      }
    ],
    "notes": [
      "Avoid overuse; investigate underlying cause if symptoms persist.",
      "Risk of serious cardiac events at high doses."
    ]
  },
  {
    "id": "ondansetron",
    "name": "Ondansetron",
    "searchTerms": [
      "ondansetron",
      "zofran"
    ],
    "className": "5-HT3 antagonist antiemetic",
    "tags": [
      "Antiemetic"
    ],
    "usualDose": "4\u20138 mg 1\u20133 times daily orally for nausea/vomiting.",
    "renalBands": [
      {
        "min": null,
        "max": null,
        "label": "All eGFR ranges",
        "category": "No renal adjustment",
        "details": "No dose change in mild\u2013moderate renal impairment; in severe CKD usual doses are often used but monitor for QT prolongation."
      }
    ],
    "notes": [
      "Use cautiously with other QT-prolonging drugs or electrolyte disturbances."
    ]
  },
  {
    "id": "levothyroxine",
    "name": "Levothyroxine",
    "searchTerms": [
      "levothyroxine",
      "thyroxine"
    ],
    "className": "Thyroid hormone replacement",
    "tags": [
      "Endocrine"
    ],
    "usualDose": "Individualised; typical maintenance 50\u2013200 micrograms once daily.",
    "renalBands": [
      {
        "min": null,
        "max": null,
        "label": "All eGFR ranges",
        "category": "TSH-guided dosing",
        "details": "No formal renal adjustment; dose to TSH and clinical response."
      }
    ],
    "notes": [
      "TSH targets may differ in elderly or cardiac disease.",
      "Take on empty stomach, separate from calcium/iron supplements."
    ]
  },
  {
    "id": "carbimazole",
    "name": "Carbimazole",
    "searchTerms": [
      "carbimazole"
    ],
    "className": "Antithyroid drug",
    "tags": [
      "Endocrine"
    ],
    "usualDose": "10\u201340 mg daily in divided doses initially, then titrated.",
    "renalBands": [
      {
        "min": null,
        "max": null,
        "label": "All eGFR ranges",
        "category": "No renal adjustment",
        "details": "No formal renal dose change; titrate to thyroid function tests."
      }
    ],
    "notes": [
      "Warn about agranulocytosis symptoms (sore throat, fever, mouth ulcers).",
      "Monitor FBC and LFTs if clinically indicated."
    ]
  },
  {
    "id": "alendronic-acid",
    "name": "Alendronic acid",
    "searchTerms": [
      "alendronate",
      "alendronic acid"
    ],
    "className": "Bisphosphonate",
    "tags": [
      "Bone health",
      "Osteoporosis"
    ],
    "usualDose": "70 mg once weekly (or 10 mg daily) for osteoporosis.",
    "renalBands": [
      {
        "min": 35,
        "max": null,
        "label": "eGFR \u2265 35",
        "category": "Standard",
        "details": "Usual dose may be used if eGFR is 35 or above."
      },
      {
        "min": null,
        "max": 35,
        "label": "eGFR < 35",
        "category": "Avoid",
        "details": "Generally avoided when eGFR is below 35 mL/min; consider alternative osteoporosis treatments."
      }
    ],
    "notes": [
      "Ensure adequate calcium/vitamin D and correct hypocalcaemia before treatment.",
      "Follow administration instructions to reduce oesophageal irritation."
    ]
  },
  {
    "id": "colecalciferol",
    "name": "Colecalciferol (vitamin D3)",
    "searchTerms": [
      "colecalciferol",
      "vitamin d"
    ],
    "className": "Vitamin D supplement",
    "tags": [
      "Bone health"
    ],
    "usualDose": "Loading or maintenance regimens vary (e.g. 800\u20132000 IU daily).",
    "renalBands": [
      {
        "min": null,
        "max": null,
        "label": "All eGFR ranges",
        "category": "No standard renal adjustment",
        "details": "Dose is guided by vitamin D level and local CKD bone-mineral guidance rather than eGFR alone."
      }
    ],
    "notes": [
      "In advanced CKD, activated vitamin D analogues may be required; follow renal team guidance."
    ]
  },
  {
    "id": "valproate",
    "name": "Sodium valproate",
    "searchTerms": [
      "sodium valproate",
      "epilim",
      "valproate"
    ],
    "className": "Antiepileptic / mood stabiliser",
    "tags": [
      "Epilepsy",
      "Bipolar"
    ],
    "usualDose": "Individualised; often 600\u20132000 mg/day in divided doses.",
    "renalBands": [
      {
        "min": null,
        "max": null,
        "label": "All eGFR ranges",
        "category": "No formal renal adjustment",
        "details": "Not significantly renally cleared; use usual doses but consider lower starting dose in frail CKD."
      }
    ],
    "notes": [
      "Serious hepatic, haematological and teratogenic risks; follow MHRA guidance.",
      "Avoid in women of childbearing potential unless absolutely necessary and within Pregnancy Prevention Programme."
    ]
  },
  {
    "id": "lamotrigine",
    "name": "Lamotrigine",
    "searchTerms": [
      "lamotrigine"
    ],
    "className": "Antiepileptic / mood stabiliser",
    "tags": [
      "Epilepsy",
      "Bipolar"
    ],
    "usualDose": "Varies by regimen and co-medication; usually 100\u2013400 mg/day.",
    "renalBands": [
      {
        "min": 30,
        "max": null,
        "label": "eGFR \u2265 30",
        "category": "Standard titration",
        "details": "Use usual titration schedule guided by seizure control and side effects."
      },
      {
        "min": null,
        "max": 30,
        "label": "eGFR < 30",
        "category": "Caution",
        "details": "Consider slower titration and lower maintenance doses; monitor for toxicity."
      }
    ],
    "notes": [
      "Warn about rash and Stevens\u2013Johnson syndrome.",
      "Check interactions with valproate and enzyme inducers."
    ]
  },
  {
    "id": "levetiracetam",
    "name": "Levetiracetam",
    "searchTerms": [
      "levetiracetam",
      "keppra"
    ],
    "className": "Antiepileptic",
    "tags": [
      "Epilepsy",
      "Renally cleared"
    ],
    "usualDose": "500\u20133000 mg/day in 2 divided doses in normal renal function.",
    "renalBands": [
      {
        "min": 80,
        "max": null,
        "label": "CrCl \u2265 80",
        "category": "Standard",
        "details": "Usual dose range according to indication."
      },
      {
        "min": 50,
        "max": 80,
        "label": "CrCl 50\u201379",
        "category": "Mild reduction",
        "details": "Slight dose reduction may be considered; check SPC for exact schedules."
      },
      {
        "min": 30,
        "max": 50,
        "label": "CrCl 30\u201349",
        "category": "Moderate reduction",
        "details": "Further reduce total daily dose; for example 250\u2013750 mg twice daily depending on indication."
      },
      {
        "min": 15,
        "max": 30,
        "label": "CrCl 15\u201329",
        "category": "Marked reduction",
        "details": "Lower doses such as 250\u2013500 mg twice daily; check SPC/local guidance."
      },
      {
        "min": null,
        "max": 15,
        "label": "CrCl < 15 / dialysis",
        "category": "Specialist dosing",
        "details": "Low daily doses with post-dialysis supplementation as per specialist guidance."
      }
    ],
    "notes": [
      "Monitor mood and behavioural changes.",
      "Adjust dose promptly if renal function changes."
    ]
  },
  {
    "id": "carbamazepine",
    "name": "Carbamazepine",
    "searchTerms": [
      "carbamazepine",
      "tegretol"
    ],
    "className": "Antiepileptic",
    "tags": [
      "Epilepsy",
      "Neuropathic pain"
    ],
    "usualDose": "Usually 400\u20131200 mg/day in divided doses.",
    "renalBands": [
      {
        "min": null,
        "max": null,
        "label": "All eGFR ranges",
        "category": "Clinical titration",
        "details": "No simple renal table; titrate to clinical response and serum levels if needed, using lower doses in frail CKD."
      }
    ],
    "notes": [
      "Enzyme inducer with many interactions; monitor sodium and FBC.",
      "Hyponatraemia is more common in older people and CKD."
    ]
  },
  {
    "id": "quetiapine",
    "name": "Quetiapine",
    "searchTerms": [
      "quetiapine",
      "seroquel"
    ],
    "className": "Atypical antipsychotic",
    "tags": [
      "Psychosis",
      "Bipolar",
      "Depression (augmentation)"
    ],
    "usualDose": "Wide range depending on indication; e.g. 50\u2013800 mg/day.",
    "renalBands": [
      {
        "min": null,
        "max": null,
        "label": "All eGFR ranges",
        "category": "No formal adjustment",
        "details": "No routine renal dose change; start low and titrate carefully in CKD."
      }
    ],
    "notes": [
      "Monitor for metabolic syndrome, QT prolongation and sedation.",
      "Use lowest effective dose, particularly in elderly CKD patients."
    ]
  },
  {
    "id": "olanzapine",
    "name": "Olanzapine",
    "searchTerms": [
      "olanzapine",
      "zyprexa"
    ],
    "className": "Atypical antipsychotic",
    "tags": [
      "Psychosis",
      "Bipolar"
    ],
    "usualDose": "5\u201320 mg once daily.",
    "renalBands": [
      {
        "min": null,
        "max": null,
        "label": "All eGFR ranges",
        "category": "No renal adjustment",
        "details": "Dose is not routinely adjusted for CKD, but use lower doses and careful titration in frail patients."
      }
    ],
    "notes": [
      "High risk of weight gain, metabolic syndrome and sedation.",
      "Monitor glucose and lipids regularly."
    ]
  },
  {
    "id": "risperidone",
    "name": "Risperidone",
    "searchTerms": [
      "risperidone"
    ],
    "className": "Atypical antipsychotic",
    "tags": [
      "Psychosis"
    ],
    "usualDose": "Commonly 2\u20136 mg/day in divided doses.",
    "renalBands": [
      {
        "min": 60,
        "max": null,
        "label": "eGFR \u2265 60",
        "category": "Standard",
        "details": "Usual dosing range may be used."
      },
      {
        "min": null,
        "max": 60,
        "label": "eGFR < 60",
        "category": "Lower starting dose",
        "details": "Use reduced starting doses and slower titration in moderate\u2013severe CKD."
      }
    ],
    "notes": [
      "Monitor for extrapyramidal symptoms and metabolic effects.",
      "Use carefully in patients with cerebrovascular disease."
    ]
  },
  {
    "id": "tamsulosin",
    "name": "Tamsulosin",
    "searchTerms": [
      "tamsulosin"
    ],
    "className": "Alpha-1 blocker (uroselective)",
    "tags": [
      "BPH",
      "Urology"
    ],
    "usualDose": "400 micrograms once daily.",
    "renalBands": [
      {
        "min": 10,
        "max": null,
        "label": "eGFR \u2265 10",
        "category": "Standard",
        "details": "No usual dose change; monitor postural BP in older adults."
      },
      {
        "min": null,
        "max": 10,
        "label": "eGFR < 10",
        "category": "Caution",
        "details": "Limited data in very severe CKD; use with caution and monitor."
      }
    ],
    "notes": [
      "May cause postural hypotension; advise patients about dizziness/falls.",
      "Can contribute to intraoperative floppy iris syndrome in cataract surgery."
    ]
  },
  {
    "id": "finasteride",
    "name": "Finasteride",
    "searchTerms": [
      "finasteride"
    ],
    "className": "5-alpha-reductase inhibitor",
    "tags": [
      "BPH"
    ],
    "usualDose": "5 mg once daily.",
    "renalBands": [
      {
        "min": null,
        "max": null,
        "label": "All eGFR ranges",
        "category": "No renal adjustment",
        "details": "No dose change typically required in CKD."
      }
    ],
    "notes": [
      "PSA falls by about 50% on treatment; interpret results accordingly.",
      "Teratogenic to male fetus; women of childbearing potential should avoid handling crushed tablets."
    ]
  },
  {
    "id": "oxybutynin",
    "name": "Oxybutynin",
    "searchTerms": [
      "oxybutynin"
    ],
    "className": "Antimuscarinic for overactive bladder",
    "tags": [
      "OAB",
      "Urology"
    ],
    "usualDose": "2.5\u20135 mg two to three times daily (or modified-release once daily).",
    "renalBands": [
      {
        "min": null,
        "max": null,
        "label": "All eGFR ranges",
        "category": "No formal renal adjustment",
        "details": "No standard dose adjustment but start low and titrate with caution in frail CKD patients."
      }
    ],
    "notes": [
      "Anticholinergic burden is significant; consider alternatives in older people with CKD.",
      "Monitor for cognitive impairment and constipation."
    ]
  },
  {
    "id": "mirabegron",
    "name": "Mirabegron",
    "searchTerms": [
      "mirabegron",
      "betmiga"
    ],
    "className": "Beta-3 agonist for overactive bladder",
    "tags": [
      "OAB",
      "Urology"
    ],
    "usualDose": "Usually 50 mg once daily (25 mg in some groups).",
    "renalBands": [
      {
        "min": 60,
        "max": null,
        "label": "eGFR \u2265 60",
        "category": "Standard dosing",
        "details": "50 mg once daily."
      },
      {
        "min": 30,
        "max": 60,
        "label": "eGFR 30\u201359",
        "category": "Standard or reduced dose",
        "details": "50 mg once daily usually acceptable; some patients may start at 25 mg if frail or on interacting drugs."
      },
      {
        "min": 15,
        "max": 30,
        "label": "eGFR 15\u201329",
        "category": "Dose reduction",
        "details": "Maximum 25 mg once daily as per SPC in moderate renal impairment with certain risk factors."
      },
      {
        "min": null,
        "max": 15,
        "label": "eGFR < 15 / dialysis",
        "category": "Avoid or specialist",
        "details": "Generally avoid in severe renal impairment; check SPC for exact restrictions."
      }
    ],
    "notes": [
      "Can raise blood pressure; avoid uncontrolled hypertension.",
      "Useful alternative when antimuscarinics are poorly tolerated."
    ]
  },
  {
    "id": "phenoxymethylpenicillin",
    "name": "Phenoxymethylpenicillin (Pen V)",
    "searchTerms": [
      "penicillin v",
      "phenoxymethylpenicillin"
    ],
    "className": "Penicillin antibiotic",
    "tags": [
      "Antibiotic"
    ],
    "usualDose": "250\u2013500 mg four times daily depending on indication.",
    "renalBands": [
      {
        "min": null,
        "max": null,
        "label": "All eGFR ranges",
        "category": "Standard",
        "details": "No dose adjustment usually required."
      }
    ],
    "notes": [
      "Preferred for tonsillitis/erysipelas in adults and children."
    ]
  },
  {
    "id": "flucloxacillin",
    "name": "Flucloxacillin",
    "searchTerms": [
      "flucloxacillin"
    ],
    "className": "Penicillin antibiotic",
    "tags": [
      "Antibiotic"
    ],
    "usualDose": "500 mg four times daily.",
    "renalBands": [
      {
        "min": 10,
        "max": null,
        "label": "eGFR \u2265 10",
        "category": "Standard",
        "details": "Usual dose is appropriate."
      },
      {
        "min": null,
        "max": 10,
        "label": "eGFR < 10",
        "category": "Caution",
        "details": "No formal renal adjustment but monitor hepatic function and for neurotoxicity in severe renal failure."
      }
    ],
    "notes": [
      "Useful for cellulitis and MSSA infections.",
      "Take on an empty stomach for better absorption."
    ]
  },
  {
    "id": "clarithromycin",
    "name": "Clarithromycin",
    "searchTerms": [
      "clarithromycin"
    ],
    "className": "Macrolide antibiotic",
    "tags": [
      "Antibiotic"
    ],
    "usualDose": "250\u2013500 mg twice daily.",
    "renalBands": [
      {
        "min": 30,
        "max": null,
        "label": "eGFR \u2265 30",
        "category": "Standard",
        "details": "Usual dosing allowed."
      },
      {
        "min": null,
        "max": 30,
        "label": "eGFR < 30",
        "category": "Dose reduction",
        "details": "Reduce dose by 50% or increase dosing interval."
      }
    ],
    "notes": [
      "Major CYP3A4 interactions; check carefully.",
      "QT prolongation risk increases in CKD."
    ]
  },
  {
    "id": "azithromycin",
    "name": "Azithromycin",
    "searchTerms": [
      "azithromycin"
    ],
    "className": "Macrolide antibiotic",
    "tags": [
      "Antibiotic"
    ],
    "usualDose": "500 mg once daily for 3 days (or other regimens depending on indication).",
    "renalBands": [
      {
        "min": null,
        "max": null,
        "label": "All eGFR ranges",
        "category": "No renal adjustment",
        "details": "No formal adjustment required."
      }
    ],
    "notes": [
      "Use caution with QT-prolonging drugs.",
      "Less CYP interaction than clarithromycin."
    ]
  },
  {
    "id": "doxycycline",
    "name": "Doxycycline",
    "searchTerms": [
      "doxycycline"
    ],
    "className": "Tetracycline antibiotic",
    "tags": [
      "Antibiotic"
    ],
    "usualDose": "200 mg day 1 then 100 mg daily.",
    "renalBands": [
      {
        "min": null,
        "max": null,
        "label": "All renal function",
        "category": "No adjustment",
        "details": "Preferred tetracycline in CKD as elimination is non-renal."
      }
    ],
    "notes": [
      "Avoid in pregnancy & in children under 12.",
      "Minimise sun exposure."
    ]
  },
  {
    "id": "ciprofloxacin",
    "name": "Ciprofloxacin",
    "searchTerms": [
      "cipro",
      "ciprofloxacin"
    ],
    "className": "Fluoroquinolone antibiotic",
    "tags": [
      "Antibiotic"
    ],
    "usualDose": "250\u2013500 mg twice daily depending on indication.",
    "renalBands": [
      {
        "min": 60,
        "max": null,
        "label": "eGFR \u2265 60",
        "category": "Standard",
        "details": "Use usual dose."
      },
      {
        "min": 30,
        "max": 60,
        "label": "eGFR 30\u201359",
        "category": "Mild reduction",
        "details": "Reduce dose (e.g. 250 mg twice daily or extend interval)."
      },
      {
        "min": null,
        "max": 30,
        "label": "eGFR < 30",
        "category": "Moderate reduction",
        "details": "Reduce further \u2013 check BNF/SPC."
      }
    ],
    "notes": [
      "Tendinopathy risk increased in CKD, older adults & steroid use.",
      "QT prolongation risk."
    ]
  },
  {
    "id": "metronidazole",
    "name": "Metronidazole",
    "searchTerms": [
      "metronidazole",
      "flagyl"
    ],
    "className": "Nitroimidazole antibiotic",
    "tags": [
      "Antibiotic"
    ],
    "usualDose": "400 mg twice or three times daily.",
    "renalBands": [
      {
        "min": null,
        "max": null,
        "label": "All renal function",
        "category": "No adjustment",
        "details": "Use usual dosing."
      }
    ],
    "notes": [
      "Reduce dose only in severe hepatic impairment.",
      "Avoid alcohol due to disulfiram-like reaction."
    ]
  },
  {
    "id": "acyclovir",
    "name": "Aciclovir",
    "searchTerms": [
      "aciclovir",
      "acyclovir"
    ],
    "className": "Antiviral",
    "tags": [
      "HSV",
      "VZV"
    ],
    "usualDose": "200\u2013800 mg depending on indication.",
    "renalBands": [
      {
        "min": 50,
        "max": null,
        "label": "eGFR \u2265 50",
        "category": "Standard",
        "details": "Usual dose."
      },
      {
        "min": 25,
        "max": 50,
        "label": "eGFR 25\u201349",
        "category": "Reduction",
        "details": "Reduce frequency (e.g. every 12 hours)."
      },
      {
        "min": 10,
        "max": 25,
        "label": "eGFR 10\u201324",
        "category": "Further reduction",
        "details": "Increase interval (e.g. every 24 hours)."
      },
      {
        "min": null,
        "max": 10,
        "label": "eGFR < 10",
        "category": "Marked reduction",
        "details": "Use extended intervals; check SPC."
      }
    ],
    "notes": [
      "Hydrate well to reduce crystalluria risk.",
      "Neurotoxicity risk increases in severe CKD."
    ]
  },
  {
    "id": "valaciclovir",
    "name": "Valaciclovir",
    "searchTerms": [
      "valaciclovir",
      "valacyclovir"
    ],
    "className": "Antiviral",
    "tags": [
      "HSV",
      "VZV"
    ],
    "usualDose": "500 mg twice daily for HSV; higher for VZV.",
    "renalBands": [
      {
        "min": 50,
        "max": null,
        "label": "eGFR \u2265 50",
        "category": "Standard",
        "details": "Usual dose."
      },
      {
        "min": 30,
        "max": 50,
        "label": "eGFR 30\u201349",
        "category": "Mild reduction",
        "details": "Reduce frequency."
      },
      {
        "min": 10,
        "max": 30,
        "label": "eGFR 10\u201329",
        "category": "Moderate reduction",
        "details": "Lower dose/frequency based on indication."
      },
      {
        "min": null,
        "max": 10,
        "label": "eGFR < 10",
        "category": "Severe reduction",
        "details": "Marked dose reduction required; check SPC."
      }
    ],
    "notes": [
      "Better oral bioavailability than aciclovir.",
      "Hydration important."
    ]
  },
  {
    "id": "prednisolone",
    "name": "Prednisolone",
    "searchTerms": [
      "prednisolone"
    ],
    "className": "Corticosteroid",
    "tags": [
      "Steroid"
    ],
    "usualDose": "Varies by indication.",
    "renalBands": [
      {
        "min": null,
        "max": null,
        "label": "All renal ranges",
        "category": "No dose change",
        "details": "Steroid doses depend on indication, not renal function."
      }
    ],
    "notes": [
      "Monitor BP, glucose, mood and infection risk.",
      "Taper slowly after long-term use."
    ]
  },
  {
    "id": "methotrexate",
    "name": "Methotrexate",
    "searchTerms": [
      "methotrexate"
    ],
    "className": "DMARD",
    "tags": [
      "Rheumatology"
    ],
    "usualDose": "7.5\u201325 mg once weekly.",
    "renalBands": [
      {
        "min": 60,
        "max": null,
        "label": "eGFR \u2265 60",
        "category": "Standard",
        "details": "Usual weekly dose may be used with monitoring."
      },
      {
        "min": 30,
        "max": 60,
        "label": "eGFR 30\u201359",
        "category": "Dose reduction",
        "details": "Consider 50\u201370% of usual dose; monitor FBC, LFTs and eGFR closely."
      },
      {
        "min": null,
        "max": 30,
        "label": "eGFR < 30",
        "category": "Avoid",
        "details": "Avoid due to risk of severe toxicity (myelosuppression)."
      }
    ],
    "notes": [
      "Ensure folic acid supplementation.",
      "Never take daily \u2014 weekly only."
    ]
  },
  {
    "id": "allopurinol-extra",
    "name": "Allopurinol (alternative entry)",
    "searchTerms": [
      "allopurinol"
    ],
    "className": "Xanthine oxidase inhibitor",
    "tags": [
      "Gout"
    ],
    "usualDose": "100\u2013300 mg daily, titrated.",
    "renalBands": [
      {
        "min": 60,
        "max": null,
        "label": "eGFR \u2265 60",
        "category": "Standard",
        "details": "May use standard titration."
      },
      {
        "min": 30,
        "max": 60,
        "label": "eGFR 30\u201359",
        "category": "Lower start",
        "details": "Start with 50\u2013100 mg daily; titrate to urate."
      },
      {
        "min": null,
        "max": 30,
        "label": "eGFR < 30",
        "category": "Specialist only",
        "details": "Use with extreme caution; hypersensitivity risk increased."
      }
    ],
    "notes": [
      "Separate duplicate entry optional \u2013 delete if unwanted.",
      "Check HLA-B*5801 in high-risk ethnic groups if available."
    ]
  },
  {
    "id": "metoclopramide",
    "name": "Metoclopramide",
    "searchTerms": [
      "metoclopramide"
    ],
    "className": "Antiemetic / prokinetic",
    "tags": [
      "GI"
    ],
    "usualDose": "10 mg up to three times daily before meals (max 30 mg/day).",
    "renalBands": [
      {
        "min": 10,
        "max": null,
        "label": "eGFR \u2265 10",
        "category": "Standard dosing",
        "details": "Use usual dosing with caution; reduce frequency in lower eGFR per local guidance."
      },
      {
        "min": null,
        "max": 10,
        "label": "eGFR < 10",
        "category": "Avoid / specialist",
        "details": "Often avoided due to increased risk of accumulation and neurological side-effects."
      }
    ],
    "notes": [
      "Prolonged use (>5 days) not recommended because of risk of tardive dyskinesia.",
      "Use lowest effective dose for shortest duration."
    ]
  },
  {
    "id": "esomeprazole",
    "name": "Esomeprazole",
    "searchTerms": [
      "esomeprazole"
    ],
    "className": "Proton pump inhibitor",
    "tags": [
      "GI"
    ],
    "usualDose": "20\u201340 mg once daily (depending on indication).",
    "renalBands": [
      {
        "min": null,
        "max": null,
        "label": "All eGFR",
        "category": "No adjustment",
        "details": "PPI dose not renally adjusted."
      }
    ],
    "notes": [
      "Long-term PPI risks (hypomagnesaemia, fractures, C. difficile) may be higher in CKD \u2014 review need regularly."
    ]
  },
  {
    "id": "allopurinol",
    "name": "Allopurinol",
    "searchTerms": [
      "allopurinol"
    ],
    "className": "Xanthine oxidase inhibitor (urate-lowering)",
    "tags": [
      "Gout"
    ],
    "usualDose": "100\u2013300 mg daily (titrated gradually).",
    "renalBands": [
      {
        "min": 60,
        "max": null,
        "label": "eGFR \u2265 60",
        "category": "Standard titration",
        "details": "Use standard initiation and titration."
      },
      {
        "min": 30,
        "max": 60,
        "label": "eGFR 30\u201359",
        "category": "Lower start",
        "details": "Start at 50\u2013100 mg daily; titrate carefully."
      },
      {
        "min": 15,
        "max": 30,
        "label": "eGFR 15\u201329",
        "category": "Cautious use",
        "details": "Consider 50 mg on alternate days; titrate slowly under monitoring."
      },
      {
        "min": null,
        "max": 15,
        "label": "eGFR < 15",
        "category": "Specialist decision",
        "details": "Use only under specialist supervision; risk of hypersensitivity increased."
      }
    ],
    "notes": [
      "Dose to serum urate and monitor for rash or signs of hypersensitivity.",
      "Ensure adequate hydration to reduce risk of xanthine nephropathy."
    ]
  },
  {
    "id": "allopurinol-highdose",
    "name": "Allopurinol (higher-dose titration)",
    "searchTerms": [
      "allopurinol high dose"
    ],
    "className": "Xanthine oxidase inhibitor",
    "tags": [
      "Gout"
    ],
    "usualDose": "Up to 300 mg daily depending on urate target.",
    "renalBands": [
      {
        "min": 60,
        "max": null,
        "label": "eGFR \u2265 60",
        "category": "Standard titration",
        "details": "Use as per urate target and local protocol."
      },
      {
        "min": 30,
        "max": 60,
        "label": "eGFR 30\u201359",
        "category": "Lower max dose",
        "details": "Aim for lower maintenance dose (e.g. \u2264 200 mg/day); monitor closely."
      },
      {
        "min": null,
        "max": 30,
        "label": "eGFR < 30",
        "category": "Specialist only",
        "details": "Use only under specialist/rheumatology guidance."
      }
    ],
    "notes": [
      "Alternative entry to existing allopurinol \u2013 helpful if local protocol distinguishes low- vs high-dose initiation."
    ]
  },
  {
    "id": "ursodeoxycholic-acid",
    "name": "Ursodeoxycholic acid",
    "searchTerms": [
      "ursodeoxycholic acid",
      "udca"
    ],
    "className": "Bile acid / hepatoprotective",
    "tags": [
      "Liver"
    ],
    "usualDose": "250\u2013500 mg 1\u20132 times daily depending on indication.",
    "renalBands": [
      {
        "min": null,
        "max": null,
        "label": "All eGFR ranges",
        "category": "No renal adjustment",
        "details": "No dose change needed for CKD."
      }
    ],
    "notes": [
      "Used in cholestatic liver disease and gallstone dissolution.",
      "Monitor LFTs regularly."
    ]
  },
  {
    "id": "prednisone",
    "name": "Prednisone",
    "searchTerms": [
      "prednisone"
    ],
    "className": "Corticosteroid",
    "tags": [
      "Steroid"
    ],
    "usualDose": "Varies widely depending on indication.",
    "renalBands": [
      {
        "min": null,
        "max": null,
        "label": "All eGFR ranges",
        "category": "No renal adjustment",
        "details": "Dosing guided by indication, not renal function."
      }
    ],
    "notes": [
      "Monitor blood pressure, glucose, electrolytes, bone health.",
      "Use lowest effective dose and taper slowly where indicated."
    ]
  },
  {
    "id": "ibuprofen",
    "name": "Ibuprofen",
    "searchTerms": [
      "ibuprofen",
      "advil",
      "nurofen"
    ],
    "className": "NSAID",
    "tags": [
      "Pain",
      "Anti-inflammatory",
      "Analgesic"
    ],
    "usualDose": "200\u2013400 mg every 4\u20136 hours (max 2400 mg/day depending on age/indication).",
    "renalBands": [
      {
        "min": 60,
        "max": null,
        "label": "eGFR \u2265 60",
        "category": "Standard",
        "details": "Use lowest effective dose for shortest duration; monitor renal function."
      },
      {
        "min": 30,
        "max": 60,
        "label": "eGFR 30\u201359",
        "category": "Caution",
        "details": "Avoid repeated courses; consider alternative analgesia."
      },
      {
        "min": null,
        "max": 30,
        "label": "eGFR < 30",
        "category": "Avoid",
        "details": "NSAIDs generally avoided due to high risk of AKI and fluid/electrolyte disturbance."
      }
    ],
    "notes": [
      "Advise sick-day rules, avoid dehydration, monitor U&E if repeated dosing.",
      "Prefer non-NSAID analgesics (paracetamol, opioids if needed) in CKD."
    ]
  },
  {
    "id": "paracetamol",
    "name": "Paracetamol",
    "searchTerms": [
      "paracetamol",
      "acetaminophen"
    ],
    "className": "Analgesic / antipyretic",
    "tags": [
      "Pain"
    ],
    "usualDose": "500\u20131000 mg every 4\u20136 hours (max 4 g/day in normal renal/hepatic function).",
    "renalBands": [
      {
        "min": null,
        "max": null,
        "label": "All eGFR ranges",
        "category": "No adjustment",
        "details": "Usual dosing acceptable; some suggest lower max dose in advanced CKD depending on comorbidities."
      }
    ],
    "notes": [
      "Safe first-line analgesic in CKD if no contraindications; monitor for liver disease if long-term use."
    ]
  },
  {
    "id": "oxycodone",
    "name": "Oxycodone (immediate release)",
    "searchTerms": [
      "oxycodone"
    ],
    "className": "Opioid analgesic",
    "tags": [
      "Pain",
      "Opioid"
    ],
    "usualDose": "5\u201310 mg every 4\u20136 hours (dose varies by tolerance and indication).",
    "renalBands": [
      {
        "min": 60,
        "max": null,
        "label": "eGFR \u2265 60",
        "category": "Standard",
        "details": "Usual doses may be used."
      },
      {
        "min": 30,
        "max": 60,
        "label": "eGFR 30\u201359",
        "category": "Caution",
        "details": "Reduce dose and extend intervals; monitor for accumulation."
      },
      {
        "min": null,
        "max": 30,
        "label": "eGFR < 30",
        "category": "Significant reduction",
        "details": "Use lower doses; consider alternative analgesia if possible."
      }
    ],
    "notes": [
      "Opioid toxicity risk increased in CKD \u2014 use lowest effective dose and monitor sedation, respiratory status, renal & fluid status."
    ]
  },
  {
    "id": "morphine",
    "name": "Morphine (immediate release)",
    "searchTerms": [
      "morphine"
    ],
    "className": "Opioid analgesic",
    "tags": [
      "Pain",
      "Opioid"
    ],
    "usualDose": "5\u201310 mg every 4 hours (subject to indication and tolerance).",
    "renalBands": [
      {
        "min": 60,
        "max": null,
        "label": "eGFR \u2265 60",
        "category": "Standard",
        "details": "Usual dosing acceptable."
      },
      {
        "min": 30,
        "max": 60,
        "label": "eGFR 30\u201359",
        "category": "Moderate reduction",
        "details": "Use lower doses and longer intervals; monitor for accumulation of active metabolites."
      },
      {
        "min": null,
        "max": 30,
        "label": "eGFR < 30",
        "category": "Significant reduction / avoid if possible",
        "details": "Prefer alternative (e.g. fentanyl, buprenorphine) if available; if used dose very cautiously."
      }
    ],
    "notes": [
      "In CKD, morphine metabolites accumulate and risk respiratory depression; use with extreme caution in advanced renal impairment."
    ]
  },
  {
    "id": "atenolol",
    "name": "Atenolol",
    "searchTerms": [
      "atenolol"
    ],
    "className": "Beta-blocker",
    "tags": [
      "Hypertension"
    ],
    "usualDose": "25\u2013100 mg daily.",
    "renalBands": [
      {
        "min": 35,
        "max": null,
        "label": "eGFR \u2265 35",
        "category": "Standard",
        "details": "Renal elimination significant; usual dosing acceptable."
      },
      {
        "min": 15,
        "max": 35,
        "label": "eGFR 15\u201334",
        "category": "Reduction",
        "details": "Reduce dose (e.g. half dose) or extend interval."
      },
      {
        "min": null,
        "max": 15,
        "label": "eGFR < 15",
        "category": "Marked reduction",
        "details": "Specialist guidance or alternative beta-blocker preferred."
      }
    ],
    "notes": [
      "Renally cleared \u2192 more bradycardia in CKD.",
      "Prefer bisoprolol or carvedilol in HF."
    ]
  },
  {
    "id": "carvedilol",
    "name": "Carvedilol",
    "searchTerms": [
      "carvedilol"
    ],
    "className": "Beta-blocker",
    "tags": [
      "Heart failure"
    ],
    "usualDose": "3.125 mg twice daily, titrated to 25\u201350 mg/day.",
    "renalBands": [
      {
        "min": null,
        "max": null,
        "label": "All eGFR ranges",
        "category": "No renal adjustment",
        "details": "Primarily hepatic metabolism; use usual titration with BP monitoring."
      }
    ],
    "notes": [
      "Useful in HF with CKD; avoid rapid dose increases.",
      "Monitor BP, renal function and fluid status."
    ]
  },
  {
    "id": "isosorbide-mononitrate",
    "name": "Isosorbide mononitrate",
    "searchTerms": [
      "isosorbide mononitrate",
      "imdur"
    ],
    "className": "Nitrate vasodilator",
    "tags": [
      "Angina"
    ],
    "usualDose": "20\u201360 mg once or twice daily depending on preparation.",
    "renalBands": [
      {
        "min": null,
        "max": null,
        "label": "All renal ranges",
        "category": "No adjustment",
        "details": "Use usual dosing; avoid tolerance by maintaining nitrate-free interval."
      }
    ],
    "notes": [
      "Headache common early on.",
      "Avoid with PDE-5 inhibitors."
    ]
  },
  {
    "id": "ranolazine",
    "name": "Ranolazine",
    "searchTerms": [
      "ranolazine"
    ],
    "className": "Anti-anginal",
    "tags": [
      "Angina"
    ],
    "usualDose": "375\u2013750 mg twice daily.",
    "renalBands": [
      {
        "min": 30,
        "max": null,
        "label": "eGFR \u2265 30",
        "category": "Cautious use",
        "details": "Start at low dose and titrate carefully."
      },
      {
        "min": null,
        "max": 30,
        "label": "eGFR < 30",
        "category": "Avoid",
        "details": "Accumulation and QT prolongation risk increased."
      }
    ],
    "notes": [
      "Monitor ECG for QT intervals.",
      "Many interactions via CYP3A4."
    ]
  },
  {
    "id": "fexofenadine",
    "name": "Fexofenadine",
    "searchTerms": [
      "fexofenadine",
      "telfast"
    ],
    "className": "Non-sedating antihistamine",
    "tags": [
      "Allergy"
    ],
    "usualDose": "120\u2013180 mg once daily.",
    "renalBands": [
      {
        "min": null,
        "max": null,
        "label": "All eGFR",
        "category": "No strong renal adjustment",
        "details": "Renal elimination increases exposure; consider lower dose in severe CKD."
      }
    ],
    "notes": [
      "Less sedating than cetirizine or loratadine.",
      "Avoid grapefruit juice (\u2193 absorption)."
    ]
  },
  {
    "id": "cetirizine",
    "name": "Cetirizine",
    "searchTerms": [
      "cetirizine",
      "zyrtec"
    ],
    "className": "Antihistamine",
    "tags": [
      "Allergy"
    ],
    "usualDose": "10 mg once daily.",
    "renalBands": [
      {
        "min": 50,
        "max": null,
        "label": "eGFR \u2265 50",
        "category": "Standard",
        "details": "Use usual dosing."
      },
      {
        "min": 10,
        "max": 50,
        "label": "eGFR 10\u201349",
        "category": "Reduction",
        "details": "Give 5 mg once daily."
      },
      {
        "min": null,
        "max": 10,
        "label": "eGFR < 10",
        "category": "Avoid or use 5 mg intermittently",
        "details": "Avoid unless benefit outweighs risk."
      }
    ],
    "notes": [
      "More sedating in renal impairment due to accumulation."
    ]
  },
  {
    "id": "loratadine",
    "name": "Loratadine",
    "searchTerms": [
      "loratadine"
    ],
    "className": "Non-sedating antihistamine",
    "tags": [
      "Allergy"
    ],
    "usualDose": "10 mg once daily.",
    "renalBands": [
      {
        "min": null,
        "max": 30,
        "label": "eGFR < 30",
        "category": "Lower dose",
        "details": "Use 5 mg once daily."
      },
      {
        "min": 30,
        "max": null,
        "label": "eGFR \u2265 30",
        "category": "Standard",
        "details": "Use usual dosing."
      }
    ],
    "notes": [
      "Metabolism hepatic but renal excretion of metabolites increases sedation risk in CKD."
    ]
  },
  {
    "id": "montelukast",
    "name": "Montelukast",
    "searchTerms": [
      "montelukast",
      "singulair"
    ],
    "className": "Leukotriene receptor antagonist",
    "tags": [
      "Asthma"
    ],
    "usualDose": "10 mg once daily (adult).",
    "renalBands": [
      {
        "min": null,
        "max": null,
        "label": "All renal ranges",
        "category": "No adjustment",
        "details": "No dose change required."
      }
    ],
    "notes": [
      "Watch for neuropsychiatric side effects.",
      "Used as add-on therapy in asthma."
    ]
  },
  {
    "id": "fluticasone-inhaled",
    "name": "Fluticasone (inhaled)",
    "searchTerms": [
      "fluticasone",
      "flixotide"
    ],
    "className": "Inhaled corticosteroid",
    "tags": [
      "Asthma"
    ],
    "usualDose": "100\u20131000 micrograms daily depending on severity.",
    "renalBands": [
      {
        "min": null,
        "max": null,
        "label": "All eGFR",
        "category": "No adjustment",
        "details": "Inhaled corticosteroid effect not determined by renal function."
      }
    ],
    "notes": [
      "Rinse mouth to prevent thrush.",
      "Monitor for systemic steroid effects at higher doses."
    ]
  },
  {
    "id": "beclometasone-inhaled",
    "name": "Beclometasone (inhaled)",
    "searchTerms": [
      "beclometasone",
      "clenil"
    ],
    "className": "Inhaled corticosteroid",
    "tags": [
      "Asthma"
    ],
    "usualDose": "100\u2013400 micrograms/day (up to 800 in severe cases).",
    "renalBands": [
      {
        "min": null,
        "max": null,
        "label": "All renal function",
        "category": "No adjustment",
        "details": "ICS not renally adjusted."
      }
    ],
    "notes": [
      "Monitor control and step up/down per asthma guidelines."
    ]
  },
  {
    "id": "salmeterol",
    "name": "Salmeterol",
    "searchTerms": [
      "salmeterol",
      "serevent"
    ],
    "className": "Long-acting beta agonist",
    "tags": [
      "Asthma",
      "COPD"
    ],
    "usualDose": "50 micrograms twice daily.",
    "renalBands": [
      {
        "min": null,
        "max": null,
        "label": "All eGFR",
        "category": "No adjustment",
        "details": "Systemic exposure low; no renal dosing required."
      }
    ],
    "notes": [
      "Never use LABA without ICS in asthma.",
      "Monitor for tremor/palpitations."
    ]
  },
  {
    "id": "clotrimazole-topical",
    "name": "Clotrimazole (topical)",
    "searchTerms": [
      "clotrimazole"
    ],
    "className": "Antifungal (topical)",
    "tags": [
      "Dermatology"
    ],
    "usualDose": "Apply 2\u20133 times daily.",
    "renalBands": [
      {
        "min": null,
        "max": null,
        "label": "All renal ranges",
        "category": "No systemic adjustment",
        "details": "Negligible systemic absorption \u2192 no renal adjustment."
      }
    ],
    "notes": [
      "Useful for candidiasis, tinea, intertrigo.",
      "Minimal interactions."
    ]
  },
  {
    "id": "acyclovir-topical",
    "name": "Aciclovir (topical)",
    "searchTerms": [
      "aciclovir topical"
    ],
    "className": "Antiviral (topical)",
    "tags": [
      "Dermatology"
    ],
    "usualDose": "Apply 5 times daily for HSV lesions.",
    "renalBands": [
      {
        "min": null,
        "max": null,
        "label": "All eGFR",
        "category": "No adjustment",
        "details": "Topical absorption minimal; no renal dosing concerns."
      }
    ],
    "notes": [
      "Limited efficacy vs oral therapy; used for mild episodes."
    ]
  },
  {
    "id": "betamethasone-topical",
    "name": "Betamethasone (topical)",
    "searchTerms": [
      "betamethasone"
    ],
    "className": "Topical corticosteroid",
    "tags": [
      "Dermatology"
    ],
    "usualDose": "Apply thin layer 1\u20132 times daily.",
    "renalBands": [
      {
        "min": null,
        "max": null,
        "label": "Not systemically dosed",
        "category": "No renal adjustment",
        "details": "Systemic absorption low unless used on large areas."
      }
    ],
    "notes": [
      "Avoid long-term use on thin skin.",
      "Monitor for local steroid atrophy."
    ]
  },
  {
    "id": "tacrolimus-topical",
    "name": "Tacrolimus ointment",
    "searchTerms": [
      "tacrolimus topical",
      "protopic"
    ],
    "className": "Topical calcineurin inhibitor",
    "tags": [
      "Dermatology"
    ],
    "usualDose": "Apply once or twice daily.",
    "renalBands": [
      {
        "min": null,
        "max": null,
        "label": "Topical only",
        "category": "No renal adjustment",
        "details": "Systemic levels minimal; avoid on large raw areas."
      }
    ],
    "notes": [
      "Useful for eczema where steroids unsuitable.",
      "Photosensitivity: advise sun protection."
    ]
  },
  {
    "id": "mesalazine",
    "name": "Mesalazine",
    "searchTerms": [
      "mesalazine",
      "5-asa"
    ],
    "className": "Aminosalicylate for IBD",
    "tags": [
      "GI",
      "IBD"
    ],
    "usualDose": "2\u20134 g/day depending on formulation.",
    "renalBands": [
      {
        "min": 60,
        "max": null,
        "label": "eGFR \u2265 60",
        "category": "Standard",
        "details": "Usual dosing acceptable."
      },
      {
        "min": 30,
        "max": 60,
        "label": "eGFR 30\u201359",
        "category": "Caution",
        "details": "Use with renal monitoring; consider lower maintenance doses."
      },
      {
        "min": null,
        "max": 30,
        "label": "eGFR < 30",
        "category": "Avoid",
        "details": "Risk of nephrotoxicity higher; specialist guidance required."
      }
    ],
    "notes": [
      "Monitor renal function regularly; mesalazine nephritis is rare but serious.",
      "Not interchangeable between brands."
    ]
  },
  {
    "id": "sulfasalazine",
    "name": "Sulfasalazine",
    "searchTerms": [
      "sulfasalazine"
    ],
    "className": "Aminosalicylate / DMARD",
    "tags": [
      "IBD",
      "Rheumatology"
    ],
    "usualDose": "500 mg\u20131 g twice daily (escalating).",
    "renalBands": [
      {
        "min": 30,
        "max": null,
        "label": "eGFR \u2265 30",
        "category": "Cautious standard",
        "details": "Monitor U&E, FBC; maintain hydration."
      },
      {
        "min": null,
        "max": 30,
        "label": "eGFR < 30",
        "category": "Caution / avoid",
        "details": "Use only with close monitoring or avoid."
      }
    ],
    "notes": [
      "Haemolysis in G6PD deficiency possible.",
      "Monitor full blood count and LFTs."
    ]
  },
  {
    "id": "ferrous-fumarate",
    "name": "Ferrous fumarate",
    "searchTerms": [
      "ferrous fumarate",
      "iron"
    ],
    "className": "Iron supplement",
    "tags": [
      "Anaemia"
    ],
    "usualDose": "200\u2013210 mg once or twice daily depending on regimen.",
    "renalBands": [
      {
        "min": null,
        "max": null,
        "label": "No renal adjustment",
        "category": "Standard",
        "details": "Use usual oral dosing."
      }
    ],
    "notes": [
      "CKD-related anaemia often requires IV iron or ESAs rather than oral supplementation.",
      "GI upset common \u2014 consider alternate-day dosing."
    ]
  },
  {
    "id": "folic-acid",
    "name": "Folic acid",
    "searchTerms": [
      "folic acid"
    ],
    "className": "Vitamin supplement",
    "tags": [
      "Anaemia"
    ],
    "usualDose": "5 mg daily (or as per indication).",
    "renalBands": [
      {
        "min": null,
        "max": null,
        "label": "All renal ranges",
        "category": "Standard",
        "details": "Oral folate is not renally dosed."
      }
    ],
    "notes": [
      "Treat underlying cause of deficiency.",
      "Used weekly alongside methotrexate (not same day)."
    ]
  },
  {
    "id": "calcium-carbonate",
    "name": "Calcium carbonate",
    "searchTerms": [
      "calcium carbonate"
    ],
    "className": "Calcium supplement / phosphate binder",
    "tags": [
      "Bone health",
      "CKD-MBD"
    ],
    "usualDose": "Varies by preparation; e.g. 1.25 g twice daily.",
    "renalBands": [
      {
        "min": null,
        "max": null,
        "label": "Not renally adjusted",
        "category": "Standard",
        "details": "Dose guided by calcium/phosphate levels, not eGFR."
      }
    ],
    "notes": [
      "Monitor calcium; risk of hypercalcaemia particularly in CKD with vitamin D therapy."
    ]
  }
]
